Heyu Biological Technology
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.26-2.05-0.11-3.16-445.45-367.57-113.74-234.39-6.33-54.46-377.66-445.45
Price/Sales ratio
5.010.150.122.66N/AN/A339.38577.1910.70183.071.42KN/A
Price/Book Value ratio
1.980.272.50-0.02-445.45-383.90-77.59-92.10-0.63-8.22-78.56-445.45
Price/Cash Flow ratio
-8.51-0.65-1.05-1.63-583.64-343.34-101.62-5.88K-7.31-49.45-1.48K-343.34
Price/Free Cash Flow ratio
-8.47-0.65-1.05-1.63-583.64-343.34-101.62-5.88K-7.31-49.45-1.48K-343.34
Price/Earnings Growth ratio
0.000.02-0.000.034.504.46-3.41-9.370.10-1.085.854.50
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
56.25%26.17%12.13%62.82%N/AN/A48.93%46.77%68.57%65.31%65.71%N/A
Operating Profit Margin
-44.29%-7.74%-50.17%-152.96%N/AN/A-328.76%-125.18%-168.78%-336.62%-378.54%N/A
Pretax Profit Margin
-71.25%-7.58%-111.47%-84.21%N/AN/A-329.92%-338.18%-168.97%-336.37%-378.28%N/A
Net Profit Margin
-221.27%-7.58%-111.47%-84.21%N/AN/A-298.37%-246.24%-168.97%-336.12%-378.28%N/A
Effective Tax Rate
-210.55%N/A-54.99%-0.63%N/AN/A9.56%27.18%N/A0.07%N/AN/A
Return on Assets
-82.19%-12.18%-830.28%N/AN/A-420.82%-57.29%-282.25%-174.26%-818.96%-1266.34%-420.82%
Return On Equity
-87.69%-13.48%-2234.25%0.87%100%104.44%68.22%39.29%10.09%15.1%23.74%104.44%
Return on Capital Employed
-17.55%-13.76%-1005.63%N/A100%104.44%90.39%17.78%8.99%13.47%20.81%104.44%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.01N/A
Quick Ratio
8.164.43N/AN/AN/A0.270.150.060.030.000.010.27
Cash ratio
6.851.54N/AN/AN/A0.120.060.000.000.000.000.12
Days of Sales Outstanding
80.8059.99N/AN/AN/AN/A187.4983.88112.0117.9860.04N/A
Days of Inventory outstanding
11.531.52N/AN/AN/AN/A1.84K-143.36-314.99185.98N/AN/A
Operating Cycle
92.3361.52N/AN/AN/AN/A2.02K-59.48-202.98203.9714.80N/A
Days of Payables Outstanding
23.953.79N/AN/AN/AN/A352.4255.03208.97215.25158.49N/A
Cash Conversion Cycle
68.3857.72N/AN/AN/AN/A1.67K-114.51-411.95-11.28-98.44N/A
Debt Ratios
Debt Ratio
0.000.00N/AN/AN/AN/A0.230.700.62N/A55.23N/A
Debt Equity Ratio
0.000.00N/AN/AN/AN/A-0.28-0.09-0.03N/A-0.90N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A-0.31-0.04N/AN/AN/AN/A
Total Debt to Capitalization
0.000.00N/AN/AN/AN/A-0.39-0.10-0.03N/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-38.26-63.36N/AN/AN/AN/A-2.68-0.15-2.43N/AN/AN/A
Company Equity Multiplier
1.061.102.69N/AN/A-0.24-1.19-0.13-0.05-0.01-0.01-0.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.58-0.23-0.11-1.63N/AN/A-3.33-0.09-1.46-3.70-0.96N/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.001111111111
Cash Flow Coverage Ratio
-38.26-63.36N/AN/AN/AN/A-2.68-0.15-2.43N/AN/AN/A
Short Term Coverage Ratio
-38.26-63.36N/AN/AN/AN/A-17.62-0.27-2.43N/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A